Number Of FDA Approvals Reached 15 Year High In 2012
Recent reports state that drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012. The FDA approved a total of 39 novel medicines last year, an increase of 30 percent when compared to a year ago.
Oncology drugs lead the way with 11 new drugs approved last year. Over the last ten years the number of FDA approvals had averaged roughly 23 a year. The passage of the Prescription Drug User Fee Act (PDUFA) played a major role in the sharp increase in approvals.
The PDUFA “has provided critical resources for improving the quality and timeliness of premarket review of drugs,” said FDA spokeswoman, Sandy Walsh. “These accomplishments could not have been achieved without the innovations of the biopharmaceutical industry and the dedication and skill of FDA's drug review staff.”
- Resilience & Reform Needed to Guard Healthcare Supply ChainsMedical Devices & Pharma
- Shoddy Chinese Syringes Sees BD Ramp-up ProductionProcurement & Supply Chain
- Prostate cancer drug fast-tracked for FDA approvalMedical Devices & Pharma
- 23andMe granted FDA Authorisation for direct-to-consumer pharmacogenetic reportsMedical Devices & Pharma
Featured Articles
NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system
Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment
A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency